z-logo
open-access-imgOpen Access
Disseminated fusariosis in a patient with bone marrow aplasia
Author(s) -
Danielle Ferreira Chagas,
Lúcia Martins Diniz,
Elton Almeida Lucas,
Paulo Sérgio Emerich Nogueira
Publication year - 2020
Publication title -
anais brasileiros de dermatologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.461
H-Index - 44
eISSN - 1806-4841
pISSN - 0365-0596
DOI - 10.1016/j.abd.2019.12.008
Subject(s) - fusariosis , medicine , neutropenia , aplasia , aspergillosis , voriconazole , dermatology , bone marrow , amphotericin b , disease , bone marrow aplasia , pathology , chemotherapy , surgery , immunology , biology , antifungal , horticulture , fusarium
Fusariosis is a superficial or systemic infection, which occurs mainly in immunocompromised hosts, especially in patients with hematological neoplasia; 70%-75% of the cases present cutaneous manifestations. The disseminated form is rare and difficult to diagnose; even with specific treatment, the evolution is usually fatal. Currently, it is considered an emerging disease; in some centers, it is the second most common cause of invasive mycosis, after aspergillosis. The authors describe a case of a female patient with idiopathic bone marrow aplasia and disseminated fusariosis, who initially appeared to benefit from voriconazole and amphotericin B; however, due to persistent neutropenia, her clinical condition deteriorated with fatal evolution.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom